In the present study, GLUT1 expression was differentially expressed in pediatric ACTs, with a higher expression in clinically malignant tumors than clinically benign tumors, and was associated with shorter overall and disease-free survival, suggesting a metabolic remodeling towards malignancy in these tumors. Here, SLC2A1 is linked to neoplasm.